ACTRN12616000802404撤回4 期
A randomised, placebo-controlled, double-blinded clinical study assessing the effectiveness and safety of modified varenicline regimens in adult smokers motivated to quit
Aaron Drovandi0 个研究点目标入组 201 人开始时间: 2016年6月20日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 发起方
- 入组人数
- 201
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Smokers motivated to quit smoking.
- •Over 18 years old.
- •Able to attend multiple visits with a researcher in Townsville.
- •Smoke more than 10 Cigarettes per day.
- •Able to refrain from using any other smoking cessation medication, and any alternative form of tobacco during the study period.
排除标准
- •Is pregnant, breastfeeding, or planning to become pregnant during the study.
- •Has a recent history of unstable cardiovascular or psychiatric conditions (stability is considered as having had no medication changes or condition deterioration in the past 6 months).
- •Has a history of a suicide attempt, and or suicidal behaviour in the previous 2 years.
- •Has an alcohol or other substance abuse disorder.
- •Has a personal history of a psychosis (schizophrenia, post-traumatic stress disorder, or bipolar disorder).
- •Has recently used varenicline (in the past 6 months).
- •Is taking any of the following medications; Naltrexone, Insulin, Nortriptyline, Clonidine, theophylline, warfarin, anorexic agents, or steroids (inhaled, or short term oral corticosteroids are permitted).
研究者
相似试验
招募中
1 期
Clinical trial of the Estrogen replacement effect on Physical Performance to muscle resistance exercise for elderly with Osteoarthritis of Knee joint.knee osteoarthritisJPRN-jRCTs061210062MITOMA TOMOHIRO80
已完成
不适用
Effect of CL19183 on metabolic rateCTRI/2021/04/032478CLS Pvt Ltd
进行中（未招募）
3 期
A randomised, double-blind, placebo-controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz (EFV) with standard dose EFV plus 2N(t)RTI in antiretroviral-naive HIV-infected individuals over 96 weeks. Encore1 intensive pharmacokinetics sub-studyHIV infectionInfection - Acquired immune deficiency syndrome (AIDS / HIV)ACTRN12612000263897Kirby Institute/University of New South Wales40
进行中（未招募）
1 期
A randomised, double-blind, placebo-controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz (EFV) with standard dose EFV plus two nucleotide reverse transcriptase inhibitors (N(t)RTI) in antiretroviral-naïve HIV-infected individuals over 96 weeks. - Encore1HIV infectionMedDRA version: 14.0 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestationsEUCTR2009-013795-44-GBational Centre in HIV Epidemiology and Clinical Research630
进行中（未招募）
3 期
A randomised, double-blind, placebo-controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz (EFV) with standard dose EFV plus two nucleotide reverse transcriptase inhibitors (N(t)RTI) in antiretroviral-naïve Human Immunodeficiency virus (HIV)-infected individuals over 96 weeks.HIV infectionInfection - Acquired immune deficiency syndrome (AIDS / HIV)ACTRN12610001097033ational Centre for HIV Epidemiology and Clinical Research630